Skip to main content

Inflammatory Breast Cancer: Clinical Presentation, Diagnosis, Staging Evaluation, Differential Diagnosis, Surgical Treatment, and Follow-Up

  • Chapter
  • First Online:
Inflammatory Breast Cancer

Abstract

Inflammatory breast cancer is a rare and aggressive form of breast cancer with a relatively poor prognosis and is characterized by a rapid onset of classic clinical and pathologic features, rapid progression, and early metastases. Several conditions may be confused with IBC, leading to delays in diagnosis and treatment. Current management of inflammatory cancer is based on multidisciplinary treatment including neoadjuvant chemotherapy and subsequent locoregional treatment including surgery and radiation therapy. Mastectomy has been proven to be an integral part of combination treatment, contributing to local control and improved survival.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Edge SB, Byrd DR, Compton CC, et al., editors. AJCC (American Joint Committee on Cancer) cancer staging manual. 7th ed. New York: Springer; 2010.

    Google Scholar 

  2. Hance KW, Anderson WF, Devesa SS, et al. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst. 2005;97:966.

    Article  PubMed  Google Scholar 

  3. Anderson WF, Schairer C, Chen BE, et al. Epidemiology of inflammatory breast cancer (IBC). Breast Dis. 2005–2006;22:9.

    Google Scholar 

  4. Tai P, Yu E, Shiels R, et al. Short- and long-term cause-specific survival of patients with inflammatory breast cancer. BMC Cancer. 2005;5:137.

    Article  PubMed  Google Scholar 

  5. Kleer CG, van Golen KL, Merajver SD. Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants. Breast Cancer Res. 2000;2:423.

    Article  PubMed  CAS  Google Scholar 

  6. Jaiyesimi IA, Buzdar AU, Hortobagyi G. Inflammatory breast cancer: a review. J Clin Oncol. 1992;10:1014.

    PubMed  CAS  Google Scholar 

  7. Walshe JM, Swain SM. Clinical aspects of inflammatory breast cancer. Breast Dis. 2005–2006;22:35.

    Google Scholar 

  8. Smoot RL, Koch CA, Degnim AC, et al. A single-center experience with inflammatory breast cancer, 1985–2003. Arch Surg. 2006;141:567.

    Article  PubMed  Google Scholar 

  9. Chow CK. Imaging in inflammatory breast carcinoma. Breast Dis. 2005–2006;22:45.

    Google Scholar 

  10. Pérez CA, Fields JN, Fracasso PM, et al. Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma. Cancer. 1994;74:466.

    Article  PubMed  Google Scholar 

  11. Thoms Jr WW, McNeese MD, Fletcher GH, et al. Multimodal treatment for inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 1989;17:739.

    Article  PubMed  Google Scholar 

  12. Baldini E, Gardin G, Evagelista G, et al. Long-term results of combined-modality therapy for inflammatory breast carcinoma. Clin Breast Cancer. 2004;5:358.

    Article  PubMed  Google Scholar 

  13. Liauw SL, Benda RK, Morris CG, Mendenhall NP. Inflammatory breast carcinoma: outcomes with trimodality therapy for nonmetastatic disease. Cancer. 2004;100:920.

    Article  PubMed  Google Scholar 

  14. Harris EE, Schultz D, Bertsch H, et al. Ten-year outcome after combined modality therapy for inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 2003;55:1200.

    Article  PubMed  Google Scholar 

  15. Palangie T, Mosseri V, Mihura J, et al. Prognostic factors in inflammatory breast cancer and therapeutic implications. Eur J Cancer. 1994;30A:921.

    Article  PubMed  CAS  Google Scholar 

  16. Hennessy BT, González-Angulo AM, Hortobagyi GN, et al. Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy. Cancer. 2006;106:1000.

    Article  PubMed  Google Scholar 

  17. Harris J., Lippman M., Morrow M., Osborne C. Diseases of the Breast 4th Edition. 2009.

    Article  PubMed  Google Scholar 

  18. Cristofanilli M, Buzdar AU, Hortobágyi GN. Update on the management of inflammatory breast cancer. Oncologist. 2003;8:141.

    Article  PubMed  CAS  Google Scholar 

  19. Liao Z, Strom EA, Buzdar AU, et al. Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence. Int J Radiat Oncol Biol Phys. 2000;47:1191.

    Article  PubMed  CAS  Google Scholar 

  20. De Boer RH, Allum WH, Ebbs SR, et al. Multimodality therapy in inflammatory breast cancer: is there a place for surgery? Ann Oncol. 2000;11:1147.

    Article  PubMed  Google Scholar 

  21. Brun B, Otmezguine Y, Feuilhade F, et al. Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation. Cancer. 1988;61:1096.

    Article  PubMed  CAS  Google Scholar 

  22. Bristol IJ, Buchholz TA. Inflammatory breast cancer: current concepts in local management. Breast Dis. 2005–2006;22:75.

    Google Scholar 

  23. Panades M, Olivotto IA, Speers CH, et al. Evolving treatment strategies for inflammatory breast cancer: a population-based survival analysis. J Clin Oncol. 2005;23:1941.

    Article  PubMed  Google Scholar 

  24. Curcio LD, Rupp E, Williams WL, et al. Beyond palliative mastectomy in inflammatory breast cancer – a reassessment of margin status. Ann Surg Oncol. 1999;6:249.

    Article  PubMed  CAS  Google Scholar 

  25. Pisansky TM, Schaid DJ, Loprinzi CL, et al. Inflammatory breast cancer: integration of irradiation, surgery, and chemotherapy. Am J Clin Oncol. 1992;15:376.

    Article  PubMed  CAS  Google Scholar 

  26. TREVES N. The inoperability of inflammatory carcinoma of the breast. Surg Gynecol Obstet. 1959 Aug; 109 (2):240–242.

    Article  PubMed  CAS  Google Scholar 

  27. Cristofanilli M, Valero V, Buzdar AU, et al. Inflam­matory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease. Cancer. 2007;110:1436.

    Article  PubMed  Google Scholar 

  28. Talwalkar SS, Miranda RN, Valbuena JR, et al. Lymphomas involving the breast: a study of 106 cases comparing localized and disseminated neoplasms. Am J Surg Pathol. 2008;32:1299.

    Article  PubMed  Google Scholar 

  29. Wong WW, Schild SE, Halyard MY, Schomberg PJ. Primary non-Hodgkin lymphoma of the breast: the mayo clinic experience. J Surg Oncol. 2002;80:19.

    Article  PubMed  Google Scholar 

  30. Kamal RM, Hamed ST, Salem DS. Classification of inflammatory breast disorders and step by step diagnosis. Breast J. 2009;15:367.

    Article  PubMed  Google Scholar 

  31. Baharoon S. Tuberculosis of the breast. Ann Thorac Med. 2008;3:110.

    Article  PubMed  Google Scholar 

  32. De la Garza-Salazar, JG, et al. Different management of inflammatory breast cancer. In: American Society of clinical oncology (meeting), Abstract C-32, Denver, 1977.

    Google Scholar 

  33. De la Garza J, et al. Cancer inflamatorio de la glándula mamaria. Experiencia de 6 años con Qt. Rt. Cir Ciruj (Mexico) 1977;45(6):351–7.

    Google Scholar 

  34. Kell MR, Marrow M. Surgical aspects of inflammatory breast cancer. Breast Dis. 2005–2006;22:67–73.

    Google Scholar 

  35. Haagensen CD (1971) Diseases of the Breast 2nd edn, Philadelphia: WB Saunders Company.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Juan Enrique Bargallo-Rocha M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Bargallo-Rocha, J.E., Shaw-Dulin, R.J., Ramirez-Ugalde, T., Herrera-Gomez, A. (2013). Inflammatory Breast Cancer: Clinical Presentation, Diagnosis, Staging Evaluation, Differential Diagnosis, Surgical Treatment, and Follow-Up. In: de la Garza-Salazar, J., Meneses-Garcia, A., Arce-Salinas, C. (eds) Inflammatory Breast Cancer. Springer, London. https://doi.org/10.1007/978-0-85729-991-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-991-8_4

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-990-1

  • Online ISBN: 978-0-85729-991-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics